• ASX 200 down 0.4%: Afterpay delivers stellar Q3 growth, Rio Tinto Q1 update

    A share market investment manager monitors share price movements on his mobile phone and laptop

    At lunch on Tuesday, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is sinking lower. The benchmark index is currently down 0.4% to 7,037.9 points.

    Here’s what is happening on the market today:

    Afterpay Q3 update

    The Afterpay Ltd (ASX: APT) share price is edging lower despite the release of a strong third quarter update. For the three months ended 31 March, Afterpay reported underlying sales growth of 104% over the prior corresponding period. Positively, the company also revealed that its gross losses continue to remain below historical rates in all operating regions. Finally, management advised that it is actively looking into listing in the United States.

    Woolworths’ investment

    The Woolworths Group Ltd (ASX: WOW) share price is lower today despite announcing a major investment. According to the release, Woolworths is investing $223 million to increase its stake in data science and advanced analytics business Quantium from 47% to 75%. Management believes the combination of Quantium’s advanced analytics capability and Woolworths’s retail capabilities can unlock value across its entire retail ecosystem.

    Rio Tinto Q1 update

    The Rio Tinto Limited (ASX: RIO) share price is trading broadly flat today following the release of its first quarter production update. For the three months ended 31 March, the company achieved Pilbara iron ore shipments of 77.8 million tonnes. This was 7% higher than the first quarter of 2020. However, production was down 2% on the prior corresponding period to 76.4 million tonnes. This was driven by above average wet weather in the mines through February and fixed plant reliability. Guidance for the full year has been maintained.

    Tech shares on watch

    The best performer on the ASX 200 on Tuesday has been the Mineral Resources Limited (ASX: MIN) share price with a 3% gain. This has been driven by a bullish broker note out of Macquarie. The worst performer has been the Challenger Ltd (ASX: CGF) share price with a 12% decline. This morning the company released its third quarter update. While its performance has been solid, investors appear disappointed that it is only guiding to the low end of its guidance range.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO and Woolworths Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX 200 down 0.4%: Afterpay delivers stellar Q3 growth, Rio Tinto Q1 update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3dzhwYM

  • Why the Money3 (ASX:MNY) share price just hit an all-time high

    Top asx share price represented by paper cutout image of mountain peaks with red flag

    The Money3 Corp Ltd (ASX: MNY) share price is on the rise in late morning trade, reaching a record high. This comes after the company announced it has been approved a new facility to support its ongoing loan book growth.

    At the time of writing, the financial services company’s shares are fetching for $3.22, up 1.26% — an all-time high.

    New facility to support growth

    Investors are pushing Money3 shares into positive territory following the company’s sights to fund growth in the New Zealand market.

    According to the release, Money3 advised its subsidiary, Go Car Finance has secured a NZ$40 million facility with Heartland Bank.

    Founded in 2011, Heartland Bank is a New Zealand-owned bank, and a subsidiary of ASX-listed Heartland Group Holdings Ltd (ASX: HGH).

    In addition, Money3 stated that the 3-year facility is an addition to the existing facility with the Bank of New Zealand. The new line of credit, however, will replace the current mezzanine finance facility. It’s also estimated that the cost of funding will be improved by more than 3% for the switch over.

    Notably, Money3 has now secured facilities from four different banks. Two in Australia and also two in New Zealand. Furthermore, the group highlighted that it’s strategic intent was to diversify its funding strategy to ensure adequate funding capacity.

    Moving into FY22, Money3 will seek to grow its loan book to more than $800 million since securing funding partners.

    Management commentary

    Money3 CEO, Scott Baldwin touched on the company’s progress, saying:

    Over the past 24 months the Go Car team have executed perfectly on our growth strategy. Growing introduction partnerships across New Zealand and growing a quality loan book allowing us to introduce Heartland Bank to the Group.

    The new facility along with the existing debt with the Bank of New Zealand will allow the group to further grow our loan book.

    Heartland Bank CEO, Chris Flood added:

    Heartland Bank is pleased to support Go Car Finance with funding for its New Zealand loan book. The funding aligns with Heartland Bank’s strategy to diversify business lending and is consistent with our long history of providing motor vehicle finance in New Zealand.

    Money3 share price summary

    In the past year, the Money3 share price has been ascending on an upwards trajectory, gaining over 120%. The company’s shares hit a record high today on the back of positive investor sentiment.

    Based on the current share price, Money3 has a market capitalisation of roughly $671 million, with 207 million shares outstanding.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Money3 (ASX:MNY) share price just hit an all-time high appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3mZqPVg

  • Why the Keytone Dairy (ASX:KTD) share price opened 23% higher today

    growth in dairy ASX share price represented by smiling cow

    The Keytone Dairy Corporation Ltd (ASX: KTD) share price is soaring today after the company released its annual revenue report for the 2021 financial year. Keytone Dairy shares opened 22.86% higher at 21.5 cents before considerably retracing. At the time of writing, the company’s shares are trading at 18.5 cents, up 5.71% for the day so far. 

    Let’s take a closer look at the dairy manufacturer and exporter’s results.

    Annual revenue results

    The Keytone Dairy share price is on the move today after the company released its unaudited results for the year ending 31 March 2021. The results show significant growth in Keytone Dairy’s sales and business divisions.

    Aside from the growth constraints caused by Australia and New Zealand’s bleakest period of the COVID-19 pandemic, the company says its brands have continued to record strong growth.

    The company’s statutory total sales revenue was up by a whopping 125% compared to the previous period.

    According to its statutory results, the year that’s been has seen Keytone Dairy rake in $50.7 million in sales revenue. This is an impressive gain when compared to the previous year’s $22.5 million revenue.

    The company’s Australian Contract Manufacturing segment also delivered robust gains. Its statutory results show it brought in $35.2 million in sales revenue, a 109% gain on the sales revenue of the prior year.

    Keytone’s New Zealand Dairy division earned $11.3 million in sales revenue over the year, an increase of 126% over the previous year.

    Finally, the company reported that its brands – including Onmiblend, which was acquired by Keytone Dairy in August 2019 – had a combined statutory income of $4.2 million. That represents an impressive 545% revenue increase on the prior corresponding period.

    Commentary from management

    Keystone CEO Danny Rotman commented on the company’s revenue results. He said:

    The record growth across the group over the last twelve months has been extraordinary, particularly given the magnitude of disruption caused by COVID to global logistics and workplace environments. The pandemic caused significant headwinds for further penetration of our own brands and our clients’ businesses. Notwithstanding these challenges, the sales growth of the business has outperformed. I am incredibly proud of the way our loyal and dedicated staff have come together to successfully navigate through this unprecedented year and the foundations that have been built as we move into FY22.

    Keytone Dairy share price snapshot

    Today’s news has resulted in a welcome boost for the Keytone Dairy share price, which has had a rough trot on the ASX lately.

    Even with today’s gains, Keytone Dairy shares are down almost 23% year to date. The company’s shares are also down by around 70% over the last 12 months.

    Keytone Dairy has a market capitalisation of around $47 million, with approximately 273 million shares outstanding.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Keytone Dairy (ASX:KTD) share price opened 23% higher today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3n0lZXT

  • Declining birth rates could threaten the A2 Milk (ASX:A2M) share price

    pouring glass of milk from glass milk bottle

    Brokers remain divided on what’s next for the battered A2 Milk Company Ltd (ASX: A2M) share price. And for once, it almost feels as though there is no right or wrong answer. 

    On one hand, A2 Milk has emerged as an iconic brand with a unique product in the dairy industry. Its shares held an Afterpay Ltd (ASX: APT) like status, driven by its outstanding growth and capital returns. This has led some brokers to highlight the potential medium-to-long term value in the company once sales channels stabilise.

    But a large part of the company’s growth story has been associated with China and Chinese-related sales channels. As the infant formula industry continues to rapidly evolve in China and with daigou channels on hold, it didn’t take long for some brokers to say it’s time to move on. 

    Another downgrade for the A2 Milk share price 

    COVID-19 may have accelerated the global phenomenon of an aging population and declining birth rates. 

    Credit Suisse has called out that the aggregate number of babies of infant formula age could be 30% lower in 2025. That is compared to 2018. 

    The broker believes that the theme of declining birth rates could see the fall of the infant formula industry contract in China. It also says that this trend could undermine the growth from increased usage of milk formula. 

    A2 Milk revenues are expected to recover in the medium-to-long term. However, the broker cites that its FY25 net profit will approach but not surpass the peak of FY20. 

    As a result, the broker rated the A2 Milk share price as underperforming with a $7.15 target price. 

    Share price snapshot 

    On a monthly chart, the A2 Milk share price has closed lower every single month since August 2020, with the exception of November 2020. November was likely propped up by the sheer strength of the broader market, with the ASX 200 rallying 10% from 5,900 to over 6,500. This perhaps reiterates why investors should avoid trying to catch a falling knife.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Declining birth rates could threaten the A2 Milk (ASX:A2M) share price appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3n9aSMb

  • Why the Altium (ASX:ALU) share price is sinking today but could rebound strongly

    The Altium Limited (ASX: ALU) share price has come under pressure on Tuesday.

    In morning trade, the electronic design software company’s shares are down 4% to $28.78.

    This compares to a 0.4% decline by the S&P/ASX 200 Index (ASX: XJO) today.

    Why is the Altium share price tumbling lower?

    Today’s decline appears to have been driven by the release of a broker note out of Citi this morning.

    Although the broker has held firm with its buy rating and $33.50 price target, some of its comments appear to have spooked investors and are weighing on the Altium share price.

    What did Citi say?

    According to the note, the broker points out that Altium has been discounting its platform, which it feels could be an indication of weak trading conditions. As a result, it fears there could be some level of pressure on its second half earnings.

    One positive, though, is that Citi’s research shows that website traffic data for its Octopart business have been solid. It also notes a positive shift in preference to its Altium 365 platform.

    Nevertheless, despite its aforementioned concerns, the broker remains positive on the company due to its belief that Altium’s downgrade cycle is nearing an end.

    Is the Altium share price in the buy zone?

    Based on the current Altium share price, Citi’s price target implies potential upside of 16.5% over the next 12 months.

    Citi isn’t alone with its buy rating. UBS currently has a buy rating and $34.00 price target on its shares and Credit Suisse has an outperform rating and $35.00 price target.

    And even more bullish are the analysts at Morgan Stanley. They currently have an overweight rating and lofty $37.00 price target on its shares.

    All four price targets suggest the Altium share price could generate market-beating returns for investors between now and this time next year. Which certainly is food for thought for investors.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Altium. The Motley Fool Australia owns shares of Altium. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Altium (ASX:ALU) share price is sinking today but could rebound strongly appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/32tVxfD

  • How Apple can afford to pay twice as much as Spotify for music streaming

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    women listening to music with headphones on her head

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Apple (NASDAQ: AAPL) recently gave itself a pat on the back when it wrote a letter to recording artists noting it pays a penny per stream on its Apple Music service. That’s about twice the rate of Spotify (NYSE: SPOT), the world’s largest streaming service.

    And while it’s leading in its payout rate on a per stream basis, it only pays out 52% of revenue to record labels. By comparison, Spotify pays out about two-thirds of its revenue to labels.

    There are a number of factors that enable Apple to pay more per stream to artists while keeping more of its revenue for itself. Here’s what investors should consider.

    The big difference between Spotify and Apple Music

    Spotify offers a free ad-supported tier for listeners, but Apple Music is subscription only. That difference in strategy has a big effect on the rates each service pays to artists and the percentage of revenue those royalties account for.

    Spotify has long held up its free ad-supported tier as an important driver of paid subscriptions in the long run. In fact, Spotify contends that offering a free tier prevents listeners from seeking “non-revenue-generating alternatives,” which you might just call “piracy.”

    But there’s a drawback to offering a free tier — less revenue per listener. As of the end of 2020, Spotify had 199 million free listeners and 155 million paid subscribers. But ad-supported revenue in the seasonally strong fourth quarter totaled just 281 million euros versus 1.89 billion euros for the paid subscribers.

    Importantly, when Spotify pays a royalty for a listener on its ad-supported tier, it pays it out of the ad-supported revenue. And with 199 million listeners, even if they’re less engaged on average than paid listeners, that’s going to drag down its average payout per stream.

    On the other hand, Spotify’s contracts with record labels typically include guaranteed minimums, which means it may have to pay additional royalties if it doesn’t generate enough engagement with the service. That could push the percentage of revenue it pays higher on average than its paid tier, where revenue is much more predictable.

    Apple doesn’t need a free tier

    Apple’s biggest advantage over Spotify is that it owns the distribution platform. While it’s possible to use Apple Music on devices not made by Apple, it’s much more common among iPhone owners. And every iPhone comes with Apple Music pre-installed. It’s the default music app. Even if you want to listen to music you’ve already downloaded, you’ll use the Apple Music app by default on an iPhone.

    That presents a big opportunity for Apple to onboard new subscribers. No need to tempt them with a free ad-supported service. No free tier means Apple’s average revenue per user is higher than Spotify’s.

    What’s more, Apple’s paid users may not be as engaged as Spotify’s paid users. If a Spotify user doesn’t use the service as much, they may not mind the occasional ad while listening. As a result, Apple generates more revenue per stream, and it pays out more per stream.

    What it all means for investors

    For Apple investors, the important number to pay attention to isn’t that it pays more per stream than Spotify. It’s that it manages to pay out only half of the revenue as royalties. A lower cost of sales, combined with Apple’s position as a platform owner, allows it to bundle Apple Music without using it as a loss leader.

    Indeed, Apple Music is at the core of Apple’s Apple One bundle, which includes all the various subscription services the company introduced over the last half decade or so. That allows Apple to profitably bolster its other services while increasing customer engagement with its services and retaining them as iPhone and Mac users year after year.

    For Spotify investors, Apple’s relatively low royalty rate is also important. It indicates there’s a lot of room for improvement in the company’s premium gross margin, which came in at 28.9% in the fourth quarter. There’s a big gap between that and the 48% Apple keeps after paying royalties, which accounts for the bulk of cost of sales. Spotify keeps its contracts with record labels short, so it frequently has an opportunity to renegotiate and improve its margins.

    Meanwhile, Spotify’s investing heavily in podcasts, both as a means to attract new users and to improve its margin for its ad-supported business. If Spotify can bring its ad-supported tier to break-even and raise the margin on its premium tier, it could become tremendously profitable given the scale the tech company’s already achieved.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Adam Levy owns shares of Apple. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple and Spotify Technology and recommends the following options: short March 2023 $130 calls on Apple and long March 2023 $120 calls on Apple. The Motley Fool Australia has recommended Apple. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post How Apple can afford to pay twice as much as Spotify for music streaming appeared first on The Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from The Motley Fool Australia https://ift.tt/3x8NHGi

  • The Stockland (ASX:SGP) share price is down this morning. Here’s why

    white arrow dropping down

    The Stockland Ltd (ASX: SGP) share price was up in early trade after the Aussie real estate investment trust’s (REIT’s) latest quarterly results. This came as Stockland provided a market update on its performance for the quarter ended 31 March 2021 (Q3 2021). However, at the time of writing, the Stockland share price has retreated to $4.59, down 0.76%. 

    What did Stockland report?

    The diversified REIT said the quarter began strongly thanks to momentum carried through from the first half of the financial year. 

    Highlights included elevated residential business enquiries boosted net sales by 69% on Q3 2020 to 1,891 lots. Additionally, Stockland is forecasting residential settlements of 6,300 lots for the full year. That’s largely thanks to “low interest rates, government incentives, and credit availability” boosting demand.

    Stockland also reported a total of 33,000 sales enquiries in its residential business — 40% above the long-term average. That comes as the Aussie housing market continues to heat up on the back of favourable macroeconomic conditions.

    Stockland said it can meet current demand levels in the current upcycle. The group has an 81,000-strong lot landbank which is ~70% activated. The Stockland share price will be worth watching in early trade after the bullish update and forecast.

    The Stockland share price will be on to watch this morning as investors react to the latest figures and forecasts. Stockland is seeing improvements in retail trading conditions as coronavirus restrictions continue to ease in Australia. The Aussie REIT is seeing sales levels and store openings increasing to around pre-COVID levels.

    Stockland reported comparable Q3 2021 total retail sales growth of 3.2% with speciality growth of 9.4%. Importantly, the group also reported low levels of “unresolved arrangements with retail tenants” helping to improve outstanding debt balances.

    Stockland said strong capital management has allowed it to restock its Communities business. The Aussie REIT has acquired 10,100 lots within the portfolio in the financial year to date. Retirement Living sales were up 16.5% on Q3 2020 figures to 190 units during the quarter.

    FY2021 guidance

    The Stockland share price is up 7.9% in 2021, outperforming the S&P/ASX 200 Index (ASX: XJO). It will be worth watching after today’s update that included a note on FY2021 guidance provided on 25 February.

    While guidance levels remain unchanged, Stockland said it expects full-year distributions at the low end of its 75% to 85% target payout ratio of funds from operations (FFO). Recent rent collections trends are expected to continue for commercial properties. Stockland is also forecasting 6,300 residential settlements for the full year per today’s release.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post The Stockland (ASX:SGP) share price is down this morning. Here’s why appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ei9sLg

  • Why the Little Green Pharma (ASX:LGP) share price is edging higher

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price

    Little Green Pharma Ltd (ASX: LGP) shares are on the rise this morning following the company’s announcement of a new European distribution deal. The Australian medicinal cannabis manufacturer has signed an agreement that will see its products sold in Denmark. At the time of writing, the Little Green Pharma share price is trading 1.31% higher at 77.5 cents.

    Let’s look closer at the company’s latest news.

    Distribution in Denmark

    Little Green Pharma has signed a 5-year, non-exclusive distribution agreement with Balancial Danmark ApS.

    The agreement will see Balancial distributing Little Green Pharma-branded cannabis oil and flower medicines in the Scandinavian nation.

    According to the company’s release, the deal is another step in its plan to grow its market share in key European medicinal cannabis markets.

    It has already nabbed entry points into Germany, France, and the United Kingdom.

    The agreement comes with certain terms and conditions. One being that Balancial cannot market or manufacture any other cannabis oil or flower products in Denmark until it has ordered 20,000 units from the Australian company.

     Another is that the Danish company must order at least 2,000 units per shipment, on a continuous basis.

    Denmark is currently more than 3 years into a 4-year trial period for the use of medicinal cannabis products. Within the trial, medicinal cannabis prescriptions are 50% reimbursed (up to US$1,500 per year) by the state, and fully reimbursed for terminally ill patients.

    Little Green Pharma states, since the trial’s introduction, medicinal cannabis patient count and prescription volumes have been growing quickly. As of February 2020, the market was expected to be worth 500 million euros and represent 2% of the population by maturity.

    Commentary from management

    Little Green Pharma’s managing director Fleta Solomon commented on the agreement:

    LGP is pleased to announce another agreement for the distribution of LGP products into a prospective EU medicinal cannabis marketplace, and looks forward to collaborating with Balancial to help service our future Danish customers.

    Little Green Pharma share price snapshot

    The Little Green Pharma share price has been performing well on the ASX lately.

    Currently, the company’s share price is up by around 38% year to date. It’s also up by around 158% over the last 12 months.

    The company has a market capitalisation of around $101 million, with approximately 187 million shares outstanding.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Little Green Pharma (ASX:LGP) share price is edging higher appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3eeyACE

  • Leading brokers name 3 ASX shares to sell today

    Business man marking Sell on board and underlining it

    On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

    Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:

    A2 Milk Company Ltd (ASX: A2M)

    According to a note out of Credit Suisse, its analysts have resumed coverage on this infant formula and fresh milk company’s shares with an underperform rating and $7.15 price target. The broker notes that Chinese birth rates are falling, which it fears could soon lead to a contraction in the infant formula industry in the lucrative market. It believes this could weigh on a2 Milk’s profit growth in the future. The a2 Milk share price is fetching $8.04 on Tuesday.

    Mayne Pharma Group Ltd (ASX: MYX)

    A note out of Macquarie reveals that its analysts have downgraded this pharmaceutical company’s shares to an underperform rating with an improved price target of 38 cents. The broker made the move partly on valuation grounds after some strong recent gains. And while Macquarie sees positives in the approval of its combined oral contraceptive Nextstellis in the United States, it isn’t enough to become more positive. Particularly given its belief that near term trading conditions will remain subdued. The Mayne Pharma share price is trading at 46.5 cents this morning.

    Sydney Airport Holdings Pty Ltd (ASX: SYD)

    Another note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this airport operator’s shares to $5.30. According to the note, the broker has increased its estimates to reflect the positive impact of the ANZ travel bubble on passenger volumes. It notes that this particular route accounted for 7% of passengers prior to the pandemic. However, even after making these adjustments, it still feels its shares are expensive at the current level. Especially given the risk associated with the roll out of COVID-19 vaccines. The Sydney Airport is currently fetching $6.06.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/32tuNMj

  • Lynas (ASX:LYC) share price down 7% despite ‘strong’ quarterly update

    energy asx share price flat represented by worker in hi vis gear shrugging

    Lynas Rare Earths Ltd (ASX: LYC) shares are retreating on Tuesday after the company provided what it called a strong March quarterly update. At the time of writing, the Lynas share price is trading 6.9% lower at $5.94.

    Let’s take a look at what the company reported.

    Lynas share price slumps despite robust demand 

    The Lynas share price is on the slide today despite the company reporting that heightened levels of demand for renewable technologies and electric vehicles saw it deliver another robust quarter.

    Total rare earth oxide production for Lynas was 4,463 tonnes and total NdPr (Neodymium and Praseodymium) production was 1,359 tonnes for the quarter. This compares to a respective 3,410 tonnes and 1,367 tonnes produced in the second quarter of FY21 (2Q21). 

    The company achieved sales revenue of $110 million for the quarter, in part due to the delay in cash collection from revenue generated in the December quarter. Invoiced revenue has continued to face delays due to the impact of COVID-19 on global trade and the blockage of the Suez Canal in March

    Rare earth spot prices continue to gain momentum with 3Q21 sales averaging $35.5/kg compared to $29.5/kg in 2Q21 and $19.8/kg in 3Q20.  

    In further news that could be dragging on the Lynas share price, the company reports that its Malaysia processing facility is operating at approximately 75% of original nameplate production. Its current focus is on improving cost performance and rare earth recoveries. According to the company, its production rate at this point in time remains sufficient to meet key customer demand while maintaining strict COVID-related health and safety protocols. 

    Lynas 2025 foundation projects pushing ahead 

    Lynas 2025 represents the company’s ambitious growth targets in driving production, diversifying its industrial footprint and becoming the supplier of choice to non-Chinese customers. 

    During the quarter, Lynas continued to progress its 2025 foundation projects. 

    These include its agreement with the United States Government to jointly fund the construction and development of a commercial Light Rare Earths separation plant in the US. Once operational, the project will secure a critical domestic source of high quality separated rare earth materials. The company is currently working through detailed engineering and design work for the heavy rare earths facility which is expected to be lodged with the US Government in the June Quarter. 

    Lynas aims to drive production capability with the expansion of a new processing facility in Kalgoorlie, Western Australia. Today’s quarterly update highlighted an approval for the commencement of limited preliminary construction works from WA Government agencies. 

    The company also announced that Prime Minister Scott Morrison publicly stated the construction of the Kalgoorlie facility is a “…gold standard example of the cooperation on critical supply chains between Australia and the US.”  

    Lynas observes that critical mineral supply chains were discussed during the recent ‘Quad’ leaders meeting between Australia, the US, Japan and India. The company believes this reiterates the importance of its development plans and industry-leading role as the largest rare earth producer outside China. 

    Despite a reasonably strong financial and operational update, the Lynas share price is slumping following the release of the update. Notwithstanding today’s weakness, the Lynas share price has still surged some 40% year to date and is within 14% of its 52-week high seen early last month. 

    Based on the current Lynas share price, the company commands a market capitalisation of around $5.7 billion.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Lynas (ASX:LYC) share price down 7% despite ‘strong’ quarterly update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2QI4cZ9